Synta Steps Out Of The Shadows With $75.3M Funding For Pipeline March 31, 2003 By Aaron Lorenzo On its website, Synta Pharmaceuticals Inc. bills itself as the newest 10-year-old pharma firm in Boston. (BioWorld Today)Read More
Synta Steps Out Of The Shadows With $75.3M Funding For Pipeline March 31, 2003 By Aaron Lorenzo On its website, Synta Pharmaceuticals Inc. bills itself as the newest 10-year-old pharma firm in Boston. (BioWorld Today)Read More
Telik Begins Registration Study Of TLK286 In Ovarian Cancer March 28, 2003 By Aaron Lorenzo Plans to push its lead compound into a Phase III trial has Telik Inc. beaming like a proud parent at a child's graduation. (BioWorld Today)Read More
Telik Begins Registration Study Of TLK286 In Ovarian Cancer March 28, 2003 By Aaron Lorenzo Plans to push its lead compound into a Phase III trial has Telik Inc. beaming like a proud parent at a child's graduation. (BioWorld Today)Read More
